Twitter | Pretraživanje | |
Pretraživanje Osvježi
Mandy Jackson 15. sij
Odgovor korisniku/ci @ScripMandy
SVB Leerink’s Cavazos says crossover VC rounds that bring in future IPO investors to companies are not going away. They used to be a nice to how & now a must have. Companies that do crossover rounds do better in their IPOs.
Reply Retweet Označi sa "sviđa mi se"
JV Public Relations NY 22. sij
FSD Pharma making a HUGE splash on Times Square!!
Reply Retweet Označi sa "sviđa mi se"
Jim Greenwood 14. sij
During at , I discussed BIO's commitment to capping out-of-pocket costs for patients in Part D. The truth is, short-sighed policies currently in front of Congress will stifle innovation and do little to help seniors better afford the medicines they need.
Reply Retweet Označi sa "sviđa mi se"
Atriva Therapeutics 13. sij
Learn more about ’s host-targeting therapy candidate against , hanta and further severe respiratory viral infections at the company presentation of our CEO, Dr. Lichtenberger, today at . Join us at 11:30, Franciscan D.
Reply Retweet Označi sa "sviđa mi se"
EBD Group 4. velj
Speaking at 2020, , of gives an update the company's progress with its investigational medicine, OV101 (gaboxadol) for the treatment of Angelman syndrome and Fragile X syndrome >>
Reply Retweet Označi sa "sviđa mi se"
EBD Group 4. velj
. executives Sol Babani and Scott Schliebner talk to us about the importance of small and emerging companies who are on the leading edge of innovation in .
Reply Retweet Označi sa "sviđa mi se"
Syneos Comms 4. velj
Michelle Keefe, President Commercial Solutions , spoke with CG Life Managing Partner Erik Clausen at 2020 to explore what the year has in store for . Listen here:
Reply Retweet Označi sa "sviđa mi se"
BlookUp 4. velj
Stay in touch about the thanks to our ! Thanks to , , or for their tweets.
Reply Retweet Označi sa "sviđa mi se"
Michaeli Avi 3. velj
This map tracks the coronavirus in real time
Reply Retweet Označi sa "sviđa mi se"
Grace E. Colón 1. velj
Reply Retweet Označi sa "sviđa mi se"
EBD Group 30. sij
Michelle Keefe, President of Commercial Solutions at explores what the year has in store for >>
Reply Retweet Označi sa "sviđa mi se"
Olderpreneurs 29. sij
Pacylex- Data from four different preclinical models suggest that PCLX-001 has robust efficacy in leukemia and lymphoma
Reply Retweet Označi sa "sviđa mi se"
Christina B Campbell 29. sij
Just as the team predicted at the media roundup at
Reply Retweet Označi sa "sviđa mi se"
Lou Regla 29. sij
The virtual liver will be the biotech breakthrough of the 2020s. Much like a real liver performing vital life functions but 100% scalable in the cloud.
Reply Retweet Označi sa "sviđa mi se"
CG Life 29. sij
Another interview is up! Hear Michelle Keefe, President of Commercial Solutions , explore what the drug industry should do to tell patient stories about positive therapeutic impact. Plus, her 2020 outlook & more!
Reply Retweet Označi sa "sviđa mi se"
AgeX Therapeutics 17. sij
AgeX Therapeutics Presenting at Four Conferences this month: > , Jan 13-15 during > PMWC 2020 Jan 21-24 > World Stem Cell Summit Jan 21-24 > Therapeutics Jan 28-30
Reply Retweet Označi sa "sviđa mi se"
Global Genes 17. sij
It was so incredible to hear about all of the new ways we can continue to advocate and educate for at this year's .
Reply Retweet Označi sa "sviđa mi se"
EuropaBio 16. sij
Odgovor korisniku/ci @EuropaBio
Three days of amazing science, collaboration and a lot of running around come to an end at - an incredible opportunity for European and to present their innovations to the 🌎
Reply Retweet Označi sa "sviđa mi se"
Mandy Jackson 16. sij
Thanks for inviting me and thank you to those who came to see us!
Reply Retweet Označi sa "sviđa mi se"
Andrew Dunn 16. sij
Super fun! Thanks for having me
Reply Retweet Označi sa "sviđa mi se"